Janet McGill

Has grant

Professor of Medicine

Washington University in St. Louis

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Janet McGill is a Professor of Medicine at Washington University in Saint Louis, USA. Her research primarily focuses on diabetes and its complications, particularly in relation to chronic kidney disease, glycemic control, and innovative treatment approaches. Recent publications include studies on the impact of medications like Finerenone and Sotagliflozin on clinical outcomes for patients with Type 1 and Type 2 diabetes, as well as insights into the management of coexisting diabetes and chronic kidney disease.

Recent Grants

Grant: Close

Diabetes Research & Training Center

Open Date: 1977-09-01

Close Date: 2013-02-22

Grant: Close

GENERAL CLINICAL RESEARCH CENTER

Open Date: 1974-10-01

Close Date: 2007-09-16

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Hiddo Lambers Heerspink

University of Groningen

NETHERLANDS

View details

Alessandro Doria

Professor of Medicine

Harvard Medical School

UNITED STATES

View details

Jennifer Green

Duke University

UNITED STATES

View details

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janet McGill

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (16)

Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia

Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus

Finerenone and Clinical Outcomes in CKD and Type 2 Diabetes by Frailty Index

Breath Acetone Correlates With Capillary β-hydroxybutyrate in Type 1 Diabetes

Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease

Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin

Management of the ‘wicked’ combination of heart failure and chronic kidney disease in the patient with diabetes

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent

A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes

Front Cover

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations

Insulin Receptor Autoantibody–mediated Hypoglycemia in a Woman With Mixed Connective Tissue Disease

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring

Update on Biosimilar Insulins: A US Perspective

Collaborators (9)

Hiddo Lambers Heerspink

Alessandro Doria

Jennifer Green

Andreas Birkenfeld

Rajiv Agarwal

Sarit Polsky

Rodica Pop-Busui

Max Petersen

Irl B. Hirsch

Make your next move.